A conversation with Dr. Will Waterfield, a successful virologist with 35 years of experience working on Polio and now Pfizer’s most profitable product Prevnar.
Thursday, May 21 2020 @6:30 PM via MSTeams
Email us for a link to the meeting: PolishAmericanBusinessClub@gmail.com
About dr. Will Waterfield
Dr. Will Waterfield began his career with Lederle Laboratories in recombinant viral research and development. (Lederle became part of Wyeth, now Pfizer).
Three years later, he moved to commercial operations and optimized bioreactor polio manufacturing, and then directed commercial operations at the Lederle site for nine years.
He was LEad on the design, construction, start up, commissioning, and licensure of Prevenar, a Pfizer vaccine for infants and children against disease caused by Streptococcus pneumonia.
Subsequently, he left commercial operations, and created the ManufacturingScience and Technology groups to remediate vaccine supply issues.
From 2012 until his departure in 2018 he focused on New Technology and Innovation attempting to identify and implement best in class and next in class technology.
In 2016-2017 he created NextGeneration Manufacturing Technologies to match process challenges with the latest technology developments for all of Pfizer: API, Solid Oral Dose, Small Molecule, Packaging, Bios Drug Substance, and Drug Product.